DuPont Reports Third Quarter 2024 Results
-
Net Sales of$3.2 billion increased 4%; organic sales increased 3% versus year-ago period - GAAP Income from continuing operations of
$480 million ; operating EBITDA of$857 million - GAAP EPS from continuing operations of
$1.13 ; adjusted EPS of$1.18 - Cash provided by operating activities from continuing operations of
$737 million ; transaction-adjusted free cash flow of$640 million - Raises guidance for full year 2024 operating EBITDA and adjusted EPS
"Our results reflect continued strong quarterly financial performance with sequential improvement across all key financial metrics," said
"I am pleased with the progress our teams are making on the intended separations of our electronics and water businesses," Koch continued. "As we advance this plan, we remain excited about the tailored strategies each future company will implement to drive sustainable growth and deliver exceptional value to shareholders, customers and employees."
|
Third Quarter 2024 Results(1) |
||||
|
Dollars in millions, unless noted |
3Q'24 |
3Q'23 |
Change vs. 3Q'23 |
Organic Sales (2) vs. 3Q'23 |
|
Net sales |
|
|
4 % |
3 % |
|
GAAP Income from continuing operations |
|
|
65 % |
|
|
Operating EBITDA(2) |
|
|
11 % |
|
|
Operating EBITDA margin(2) % |
26.8 % |
25.3 % |
150 bps |
|
|
GAAP EPS from continuing operations |
|
|
82 % |
|
|
Adjusted EPS(2) |
|
|
28 % |
|
|
Cash provided by operating activities – cont. ops. |
|
|
- % |
|
|
Transaction-adjusted free cash flow(2) |
|
|
3 % |
|
Net sales
- Net sales increased 4% as organic sales(2) growth of 3% and a favorable portfolio impact of 2% were partially offset by a 1% currency headwind. Organic sales(2) growth reflected a 5% increase in volume partially offset by a 2% decrease in price. Higher volume was driven by continued strong growth in electronics end-markets coupled with a return to year-over-year growth in Water Solutions.
- 10% organic sales(2) growth in Electronics & Industrial; 2% organic sales(2) decline in Water & Protection; 6% organic sales(2) decline in the retained businesses reported in Corporate & Other.
- 9% organic sales(2) growth in
Asia Pacific ; 1% organic sales(2) growth in EMEA; 2% organic sales(2) decline inU.S. &Canada .
GAAP Income from continuing operations
- GAAP income/GAAP EPS from continuing operations increased as higher segment earnings, non-cash gains on interest rate swaps and benefits of a lower share count and tax rate were partially offset by higher transaction costs.
Operating EBITDA (2)
- Operating EBITDA(2) increased as volume gains, the impact of higher production rates and savings from restructuring actions were partially offset by higher variable compensation and select growth investments.
Adjusted EPS (2)
- Adjusted EPS(2) increased due to higher segment earnings and benefits of a lower share count and tax rate.
Cash provided by operating activities from continuing operations
- Cash provided by operating activities from continuing operations in the quarter of
$737 million , capital expenditures of$109 million and transaction cost payments for the Intended Business Separations of$12 million resulted in transaction-adjusted free cash flow and related conversion(2) of$640 million and 130%, respectively.
|
(1) |
Results and cash flows are presented on a continuing operations basis. See page 5 for further information, including the basis of presentation included in this release. |
|
(2) |
Organic sales, operating EBITDA, operating EBITDA margin, adjusted EPS, transaction-adjusted free cash flow and transaction-adjusted free cash flow conversion are non-GAAP measures and only reflect continuing operations. See pages 6-7 for further discussion, including a definition of significant items. Reconciliation to the most directly comparable GAAP measure, including details of significant items begins on page 12 of this communication. |
|
(3) |
During first quarter 2024, the Company realigned the management and reporting structure of certain product lines within the three E&I lines of business. E&I line of business revenue amounts for historical periods have been recast to conform to the new structure. |
|
Third Quarter 2024 Segment Highlights |
||||
|
|
||||
|
Electronics & Industrial |
||||
|
Dollars in millions, unless noted |
3Q'24 |
3Q'23 |
Change vs. 3Q'23 |
Organic Sales(2) vs. 3Q'23 |
|
Net sales |
|
|
13 % |
10 % |
|
Operating EBITDA |
|
|
22 % |
|
|
Operating EBITDA margin % |
30.1 % |
28.0 % |
210 bps |
|
Net sales
- Net sales increased 13% as organic sales(2) growth of 10% and a favorable portfolio impact of 4% was slightly offset by a currency headwind of 1%.
- Organic sales(2) growth of 10% reflects an 11% increase in volume slightly offset by a 1% decrease in price.
- Semiconductor Technologies(3) sales up more than 20% on an organic(2) basis on continued semiconductor demand recovery, primarily driven by AI technology applications and increased
China demand. - Interconnect Solutions(3) sales up low-double digits on an organic(2) basis reflecting broad-based consumer electronics recovery, share gains and volume benefits from AI-driven technology ramps.
- Industrial Solutions(3) sales down slightly on an organic(2) basis as strength in printing and packaging applications was offset by ongoing Kalrez® channel inventory destocking.
- Semiconductor Technologies(3) sales up more than 20% on an organic(2) basis on continued semiconductor demand recovery, primarily driven by AI technology applications and increased
Operating EBITDA
- Operating EBITDA increased as volume gains, the impact of higher production rates, savings from productivity and restructuring actions and the earnings contribution from the Spectrum and Donatelle acquisitions were partially offset by higher variable compensation and select growth investments.
- Operating EBITDA margin of 30.1% increased 210 basis points.
|
Water & Protection |
|
Dollars in millions, unless noted |
3Q'24 |
3Q'23 |
Change vs. 3Q'23 |
Organic Sales(2) vs. 3Q'23 |
|
Net sales |
|
|
(2) % |
(2) % |
|
Operating EBITDA |
|
|
1 % |
|
|
Operating EBITDA margin % |
26.3 % |
25.6 % |
70 bps |
|
Net sales
- Net sales decreased 2% due to a decrease in price while volume was flat.
- Safety Solutions sales down mid-single digits on an organic(2) basis due to a decrease in price along with year-over-year volume declines for medical packaging products. On a sequential basis, medical packaging sales increased 10% in the third quarter.
- Shelter Solutions sales down slightly on an organic(2) basis due to headwinds in
North America residential construction markets mostly offset by growth in commercial construction. - Water Solutions sales up low-single digits on an organic(2) basis driven by strength in ultrafiltration technologies along with continued volume recovery in
China . On a sequential basis, Water Solutions sales increased 3% in the third quarter.
Operating EBITDA
- Operating EBITDA increased as productivity and savings from restructuring actions more than offset the organic revenue decline and higher variable compensation.
- Operating EBITDA margin of 26.3% increased 70 basis points.
|
Financial Outlook |
|||
|
|
|||
|
Dollars in millions, unless noted |
4Q'24E |
Current Full Year 2024E |
Prior Full Year 2024E |
|
Net sales |
|
|
|
|
Operating EBITDA(2) |
|
|
|
|
Adjusted EPS(2) |
|
|
|
"We continue to build momentum and I am pleased with our third quarter financial performance, including another strong quarter of cash generation," said
"On a full year basis, we are raising our earnings guidance and now expect operating EBITDA of about
Conference Call
The Company will host a live webcast of its quarterly earnings conference call with investors to discuss its results and business outlook beginning today at
About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.
DuPontTM and all products, unless otherwise noted, denoted with TM, SMor ® are trademarks, service marks or registered trademarks of affiliates of
Overview
On
Effective as of
On
Cautionary Statement about Forward-looking Statements
This communication contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target, "outlook," "stabilization," "confident," "preliminary," "initial," and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements, including statements regarding outlook, expectations and guidance. Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which that are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements.
Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) the ability of DuPont to effect the separation transactions described above and to meet the conditions related thereto; (ii) the possibility that the separation transactions will not be completed within the anticipated time period or at all; (iii) the possibility that the separation transactions will not achieve their intended benefits; (iv) the impact of the separation transactions on DuPont's businesses and the risk that the separations may be more difficult, time-consuming or costly than expected, including the impact on DuPont's resources, systems, procedures and controls, diversion of management's attention and the impact and possible disruption of existing relationships with customers, suppliers, employees and other business counterparties; (v) the possibility of disruption, including disputes, litigation or unanticipated costs, in connection with the separation transactions; (vi) the uncertainty of the expected financial performance of DuPont or the separated companies following completion of the separation transactions; (vii) negative effects of the announcement or pendency of the separation transactions on the market price of DuPont's securities and/or on the financial performance of DuPont; (viii) the ability to achieve anticipated capital structures in connection with the separation transactions, including the future availability of credit and factors that may affect such availability; (ix) the ability to achieve anticipated credit ratings in connection with the separation transactions; (x) the ability to achieve anticipated tax treatments in connection with the separation transactions and completed and future, if any, divestitures, mergers, acquisitions and other portfolio changes and the impact of changes in relevant tax and other laws; (xi) risks and uncertainties related to the settlement agreement concerning PFAS liabilities reached
Non-GAAP Financial Measures
Unless otherwise indicated, all financial metrics presented reflect continuing operations only.
This communication includes information that does not conform to accounting principles generally accepted in
Indirect costs, such as those related to corporate and shared service functions previously allocated to the Delrin® Divestiture, do not meet the criteria for discontinued operations and were reported within continuing operations in the respective prior periods. A portion of these historical indirect costs include costs related to activities the Company is undertaking on behalf of Delrin® and for which it is reimbursed ("Future Reimbursable Indirect Costs"). Future Reimbursable Indirect Costs are reported within continuing operations but are excluded from operating EBITDA as defined below. The remaining portion of these indirect costs is not subject to future reimbursement ("Stranded Costs"). Stranded Costs are reported within continuing operations in Corporate & Other and are included within Operating EBITDA.
Adjusted Earnings (formerly referred to as "Adjusted results") is defined as income from continuing operations excluding the after-tax impact of significant items, after-tax impact of amortization expense of intangibles, the after-tax impact of non-operating pension / other post employment benefits ("OPEB") credits / costs and Future Reimbursable Indirect Costs. Adjusted Earnings is the numerator used in the calculation of Adjusted EPS, as well as the denominator in Adjusted Free Cash Flow Conversion.
Adjusted EPS is defined as Adjusted Earnings per common share - diluted. Management estimates amortization expense in 2024 associated with intangibles to be about
The Company's measure of profit/loss for segment reporting purposes is Operating EBITDA as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines Operating EBITDA as earnings (i.e., "Income from continuing operations before income taxes") before interest, depreciation, amortization, non-operating pension / OPEB benefits / charges, and foreign exchange gains / losses, excluding Future Reimbursable Indirect Costs, and adjusted for significant items. Reconciliations of these measures are provided on the following pages.
Operating EBITDA Margin is defined as Operating EBITDA divided by
Incremental Margin is the change in Operating EBITDA divided by the change in
Significant items are items that arise outside the ordinary course of the Company's business that management believes may cause misinterpretation of underlying business performance, both historical and future, based on a combination of some or all of the item's size, unusual nature and infrequent occurrence. Management classifies as significant items certain costs and expenses associated with integration and separation activities related to transformational acquisitions and divestitures as they are considered unrelated to ongoing business performance.
Organic Sales is defined as net sales excluding the impacts of currency and portfolio.
Non-GAAP Financial Measures (continued)
Adjusted Free Cash Flow is defined as cash provided by/used for operating activities from continuing operations less capital expenditures and excluding the impact of cash inflows/outflows that are unusual in nature and/or infrequent in occurrence that neither relate to the ordinary course of the Company's business nor reflect the Company's underlying business liquidity. As a result, Adjusted Free Cash Flow represents cash that is available to the Company, after investing in its asset base, to fund obligations using the Company's primary source of liquidity, cash provided by operating activities from continuing operations. Management believes Adjusted Free Cash Flow, even though it may be defined differently from other companies, is useful to investors, analysts and others to evaluate the Company's cash flow and financial performance, and it is an integral measure used in the Company's financial planning process. Management notes that there were no exclusions for items that are unusual in nature and/or infrequent in occurrence for the three and nine-month periods ended
Adjusted Free Cash Flow Conversion is defined as Adjusted Free Cash Flow divided by Adjusted Earnings. Management uses Adjusted Free Cash Flow Conversion as an indicator of our ability to convert earnings to cash.
Supplemental non-GAAP financial measures are presented beginning in the third quarter of 2024. Management believes the Intended Business Separations represent a significant transformational change for the Company and the impact of transaction cost payments associated with the separations are expected to be material to the Company's financial statements. Management believes the supplemental non-GAAP financial measures Transaction-Adjusted Free Cash Flow and Transaction-Adjusted Free Cash Flow Conversion (each defined below) provide an integral view of information on the Company's underlying business performance during this period of transformational change. Management believes Transaction-Adjusted Free Cash Flow, which may be defined differently from other companies, is useful to investors, analysts and others to evaluate the Company's cash flow and financial performance, and it is an integral measure used in the Company's financial planning process. These non-GAAP financial measures are not intended to represent residual cash flow for discretionary expenditures since other non-discretionary expenditures, such as mandatory debt service requirements, are not deducted from the measure.
Transaction-Adjusted Free Cash Flow is defined as cash provided by/used for operating activities from continuing operations less capital expenditures, transaction cost payments associated with the Intended Business Separations and excluding the impact of cash inflows/outflows that are unusual in nature and/or infrequent in occurrence that neither relate to the ordinary course of the Company's business nor reflect the Company's underlying business liquidity.
Transaction-Adjusted Free Cash Flow Conversion is defined as Adjusted Free Cash Flow excluding transaction costs associated with the Intended Business Separations divided by Adjusted Earnings.
|
Consolidated Statements of Operations
|
||||
|
|
||||
|
In millions, except per share amounts (Unaudited) |
Three Months Ended |
Nine Months Ended |
||
|
2024 |
2023 |
2024 |
2023 |
|
|
Net sales |
$ 3,192 |
$ 3,058 |
$ 9,294 |
$ 9,170 |
|
Cost of sales |
1,998 |
1,954 |
5,912 |
5,967 |
|
Research and development expenses |
134 |
128 |
393 |
380 |
|
Selling, general and administrative expenses |
387 |
360 |
1,189 |
1,058 |
|
Amortization of intangibles |
149 |
155 |
449 |
448 |
|
Restructuring and asset related charges - net |
21 |
8 |
68 |
39 |
|
Acquisition, integration and separation costs |
43 |
9 |
51 |
15 |
|
Equity in earnings of nonconsolidated affiliates |
14 |
11 |
49 |
40 |
|
Sundry income (expense) - net |
199 |
55 |
150 |
112 |
|
Interest expense |
87 |
102 |
282 |
295 |
|
Income from continuing operations before income taxes |
$ 586 |
$ 408 |
$ 1,149 |
$ 1,120 |
|
Provision for income taxes on continuing operations |
106 |
117 |
310 |
287 |
|
Income from continuing operations, net of tax |
$ 480 |
$ 291 |
$ 839 |
$ 833 |
|
(Loss) income from discontinued operations, net of tax |
(18) |
37 |
5 |
(357) |
|
Net income |
$ 462 |
$ 328 |
$ 844 |
$ 476 |
|
Net income attributable to noncontrolling interests |
8 |
9 |
23 |
31 |
|
Net income available for DuPont common stockholders |
$ 454 |
$ 319 |
$ 821 |
$ 445 |
|
|
||||
|
Per common share data: |
|
|
|
|
|
Earnings per common share from continuing operations - basic |
$ 1.13 |
$ 0.62 |
$ 1.95 |
$ 1.76 |
|
(Loss) earnings per common share from discontinued operations - basic |
(0.04) |
0.08 |
0.01 |
(0.78) |
|
Earnings per common share - basic |
$ 1.09 |
$ 0.71 |
$ 1.96 |
$ 0.97 |
|
Earnings per common share from continuing operations - diluted |
$ 1.13 |
$ 0.62 |
$ 1.94 |
$ 1.75 |
|
(Loss) earnings per common share from discontinued operations - diluted |
(0.04) |
0.08 |
0.01 |
(0.78) |
|
Earnings per common share - diluted |
$ 1.08 |
$ 0.70 |
$ 1.95 |
$ 0.97 |
|
|
||||
|
Weighted-average common shares outstanding - basic |
417.9 |
451.7 |
419.5 |
456.5 |
|
Weighted-average common shares outstanding - diluted |
419.5 |
453.4 |
420.8 |
457.8 |
|
Consolidated Balance Sheets
|
||
|
|
||
|
In millions, except share amounts (Unaudited) |
|
|
|
Assets |
|
|
|
Current Assets |
|
|
|
Cash and cash equivalents |
$ 1,645 |
$ 2,392 |
|
Restricted cash and cash equivalents |
6 |
411 |
|
Accounts and notes receivable - net |
2,363 |
2,370 |
|
Inventories |
2,237 |
2,147 |
|
Prepaid and other current assets |
188 |
194 |
|
Total current assets |
$ 6,439 |
$ 7,514 |
|
Property, plant and equipment - net of accumulated depreciation ( |
5,784 |
5,884 |
|
Other Assets |
|
|
|
|
16,868 |
16,720 |
|
Other intangible assets |
5,579 |
5,814 |
|
Restricted cash and cash equivalents - noncurrent |
35 |
— |
|
Investments and noncurrent receivables |
1,120 |
1,071 |
|
Deferred income tax assets |
287 |
312 |
|
Deferred charges and other assets |
1,349 |
1,237 |
|
Total other assets |
$ 25,238 |
$ 25,154 |
|
Total Assets |
$ 37,461 |
$ 38,552 |
|
Liabilities and Equity |
|
|
|
Current Liabilities |
|
|
|
Accounts payable |
1,702 |
1,675 |
|
Income taxes payable |
138 |
154 |
|
Accrued and other current liabilities |
985 |
1,269 |
|
Total current liabilities |
$ 2,825 |
$ 3,098 |
|
Long-Term Debt |
7,170 |
7,800 |
|
Other Noncurrent Liabilities |
|
|
|
Deferred income tax liabilities |
1,027 |
1,130 |
|
Pension and other post-employment benefits - noncurrent |
560 |
565 |
|
Other noncurrent obligations |
1,222 |
1,234 |
|
Total other noncurrent liabilities |
$ 2,809 |
$ 2,929 |
|
Total Liabilities |
$ 12,804 |
$ 13,827 |
|
Commitments and contingent liabilities |
|
|
|
Stockholders' Equity |
|
|
|
Common stock (authorized 1,666,666,667 shares of |
4 |
4 |
|
Additional paid-in capital |
48,059 |
48,059 |
|
Accumulated deficit |
(22,959) |
(22,874) |
|
Accumulated other comprehensive loss |
(892) |
(910) |
|
Total DuPont stockholders' equity |
$ 24,212 |
$ 24,279 |
|
Noncontrolling interests |
445 |
446 |
|
Total equity |
$ 24,657 |
$ 24,725 |
|
Total Liabilities and Equity |
$ 37,461 |
$ 38,552 |
|
Consolidated Statement of Cash Flows
|
||
|
|
||
|
In millions (Unaudited) |
Nine Months Ended |
|
|
2024 |
2023 |
|
|
Operating Activities |
|
|
|
Net income |
$ 844 |
$ 476 |
|
Income (loss) from discontinued operations |
5 |
(357) |
|
Net income from continuing operations |
$ 839 |
$ 833 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
Depreciation and amortization |
895 |
853 |
|
Credit for deferred income tax and other tax related items |
(87) |
(40) |
|
Earnings of nonconsolidated affiliates in excess of dividends received |
(31) |
(13) |
|
Net periodic pension benefit costs |
7 |
23 |
|
Periodic benefit plan contributions |
(50) |
(49) |
|
Net gain on sales of assets, businesses and investments |
(5) |
(8) |
|
Restructuring and asset related charges - net |
68 |
39 |
|
Loss on debt extinguishment |
74 |
— |
|
Interest rate swap gain |
(152) |
— |
|
Other net loss |
67 |
72 |
|
Changes in assets and liabilities, net of effects of acquired and divested companies: |
|
|
|
Accounts and notes receivable |
(173) |
100 |
|
Inventories |
(69) |
57 |
|
Accounts payable |
112 |
(191) |
|
Other assets and liabilities, net |
262 |
(131) |
|
Cash provided by operating activities - continuing operations |
$ 1,757 |
$ 1,545 |
|
Investing Activities |
|
|
|
Capital expenditures |
(418) |
(474) |
|
Proceeds and adjustments to proceeds from sales of property and businesses, net of cash divested |
(7) |
16 |
|
Acquisitions of property and businesses, net of cash acquired |
(320) |
(1,761) |
|
Purchases of investments |
— |
(32) |
|
Proceeds from sales and maturities of investments |
— |
1,334 |
|
Other investing activities, net |
20 |
(2) |
|
Cash used for investing activities - continuing operations |
$ (725) |
$ (919) |
|
Financing Activities |
|
|
|
Changes in short-term borrowings |
— |
175 |
|
Payments on long-term debt |
(687) |
— |
|
Purchases of common stock and forward contracts |
(500) |
(2,000) |
|
Proceeds from issuance of Company stock |
43 |
22 |
|
Employee taxes paid for share-based payment arrangements |
(26) |
(25) |
|
Distributions to noncontrolling interests |
(24) |
(34) |
|
Dividends paid to stockholders |
(476) |
(495) |
|
Other financing activities, net |
(1) |
(2) |
|
Cash used for financing activities - continuing operations |
$ (1,671) |
$ (2,359) |
|
Cash Flows from Discontinued Operations |
|
|
|
Cash used for operations - discontinued operations |
(469) |
(176) |
|
Cash used for investing activities - discontinued operations |
— |
(60) |
|
Cash used in discontinued operations |
$ (469) |
$ (236) |
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
(9) |
(56) |
|
Decrease in cash, cash equivalents and restricted cash |
$ (1,117) |
$ (2,025) |
|
Cash, cash equivalents and restricted cash from continuing operations, beginning of period |
2,803 |
3,772 |
|
Cash, cash equivalents and restricted cash from discontinued operations, beginning of period |
— |
— |
|
Cash, cash equivalents and restricted cash at beginning of period |
$ 2,803 |
$ 3,772 |
|
Cash, cash equivalents and restricted cash from continuing operations, end of period |
1,686 |
1,747 |
|
Cash, cash equivalents and restricted cash from discontinued operations, end of period |
— |
— |
|
Cash, cash equivalents and restricted cash at end of period |
$ 1,686 |
$ 1,747 |
|
|
||||
|
|
||||
|
|
Three Months Ended |
Nine Months Ended |
||
|
In millions (Unaudited) |
|
|
|
|
|
Electronics & Industrial |
$ 1,551 |
$ 1,368 |
$ 4,424 |
$ 3,976 |
|
Water & Protection |
1,382 |
1,413 |
4,064 |
4,356 |
|
Corporate & Other 1 |
259 |
277 |
806 |
838 |
|
Total |
$ 3,192 |
$ 3,058 |
$ 9,294 |
$ 9,170 |
|
|
$ 1,112 |
$ 1,093 |
$ 3,292 |
$ 3,161 |
|
EMEA 2 |
538 |
535 |
1,632 |
1,702 |
|
|
1,411 |
1,302 |
3,995 |
3,945 |
|
|
131 |
128 |
375 |
362 |
|
Total |
$ 3,192 |
$ 3,058 |
$ 9,294 |
$ 9,170 |
|
Net Sales Variance by Segment
and |
Three Months Ended |
|
|||||
|
Local Price & |
Volume |
Total Organic |
Currency |
Portfolio / Other |
Total |
|
|
|
Percent change from prior year (Unaudited) |
|
||||||
|
Electronics & Industrial |
(1) % |
11 % |
10 % |
(1) % |
4 % |
13 % |
|
|
Water & Protection |
(2) |
— |
(2) |
— |
— |
(2) |
|
|
Corporate & Other 1 |
(2) |
(4) |
(6) |
— |
— |
(6) |
|
|
Total |
(2) % |
5 % |
3 % |
(1) % |
2 % |
4 % |
|
|
|
(1) % |
(1) % |
(2) % |
— % |
4 % |
2 % |
|
|
EMEA2 |
(1) |
2 |
1 |
(1) |
1 |
1 |
|
|
|
(2) |
11 |
9 |
(1) |
— |
8 |
|
|
|
(3) |
4 |
1 |
(1) |
2 |
2 |
|
|
Total |
(2) % |
5 % |
3 % |
(1) % |
2 % |
4 % |
|
|
Net Sales Variance by Segment |
Nine Months Ended |
|
|||||
|
Local Price & |
Volume |
Total Organic |
Currency |
Portfolio / Other |
Total |
|
|
|
Percent change from prior year |
|
||||||
|
Electronics & Industrial |
(2) % |
7 % |
5 % |
(1) % |
7 % |
11 % |
|
|
Water & Protection |
(1) |
(5) |
(6) |
(1) |
— |
(7) |
|
|
Corporate & Other 1 |
(2) |
(2) |
(4) |
— |
— |
(4) |
|
|
Total |
(2) % |
1 % |
(1) % |
(1) % |
3 % |
1 % |
|
|
|
(1) % |
(3) % |
(4) % |
— % |
8 % |
4 % |
|
|
EMEA2 |
(2) |
(3) |
(5) |
— |
1 |
(4) |
|
|
|
(2) |
5 |
3 |
(2) |
— |
1 |
|
|
|
(1) |
1 |
— |
— |
4 |
4 |
|
|
Total |
(2) % |
1 % |
(1) % |
(1) % |
3 % |
1 % |
|
|
|
|
|
1. |
|
|
2. |
|
|
3. |
Net sales attributed to |
|
Selected Financial Information and Non-GAAP Measures
|
|
||||
|
|
|
||||
|
Operating EBITDA by Segment |
Three Months Ended |
Nine Months Ended |
|
||
|
In millions (Unaudited) |
|
|
|
|
|
|
Electronics & Industrial |
$ 467 |
$ 383 |
$ 1,260 |
$ 1,094 |
|
|
Water & Protection |
364 |
362 |
1,003 |
1,074 |
|
|
Corporate & Other 1 |
26 |
30 |
74 |
59 |
|
|
Total |
$ 857 |
$ 775 |
$ 2,337 |
$ 2,227 |
|
|
1. In addition to corporate expenses, Corporate & Other includes activities of the Retained Businesses which include the Auto Adhesives & Fluids, |
|
||||
|
|
|
|
|
|
|
|
Equity in Earnings of Nonconsolidated Affiliates by Segment |
Three Months Ended |
Nine Months Ended |
|
||
|
In millions (Unaudited) |
|
|
|
|
|
|
Electronics & Industrial |
$ 10 |
$ 3 |
$ 33 |
$ 11 |
|
|
Water & Protection |
5 |
8 |
22 |
29 |
|
|
Corporate & Other 1 |
(1) |
— |
(6) |
— |
|
|
Total equity earnings included in operating EBITDA (GAAP) |
$ 14 |
$ 11 |
$ 49 |
$ 40 |
|
|
1. Corporate & Other includes the equity interest acquired in the Delrin® Divestiture transaction. |
|
|
|||
|
|
|
|
|
|
|
|
Reconciliation of "Income from continuing operations, net of tax" to |
Three Months Ended |
Nine Months Ended |
|
||
|
|
|||||
|
In millions (Unaudited) |
|
|
|
|
|
|
Income from continuing operations, net of tax (GAAP) |
$ 480 |
$ 291 |
$ 839 |
$ 833 |
|
|
+ Provision for income taxes on continuing operations |
106 |
117 |
310 |
287 |
|
|
Income from continuing operations before income taxes |
$ 586 |
$ 408 |
$ 1,149 |
$ 1,120 |
|
|
+ Depreciation and amortization |
306 |
294 |
895 |
853 |
|
|
- Interest income 1 |
14 |
34 |
55 |
132 |
|
|
+ Interest expense 1, 2 |
86 |
102 |
281 |
295 |
|
|
- Non-operating pension/OPEB benefit credits (costs) 1 |
4 |
(3) |
14 |
(7) |
|
|
- Foreign exchange (losses) gains, net 1 |
(19) |
17 |
(19) |
(31) |
|
|
+ Future reimbursable indirect costs |
— |
2 |
— |
6 |
|
|
- Significant items benefit (charge) |
122 |
(17) |
(62) |
(47) |
|
|
Operating EBITDA (non-GAAP) |
$ 857 |
$ 775 |
$ 2,337 |
$ 2,227 |
|
|
|
|
|
1. |
Included in "Sundry income (expense) - net." |
|
2. |
The three month and nine month period ended |
|
Reconciliation of "Cash provided by operating activities - continuing |
Three Months Ended |
Nine Months Ended |
||
|
In millions (Unaudited) |
|
|
|
|
|
Cash provided by operating activities (GAAP) 2 - continuing operations |
$ 737 |
$ 740 |
$ 1,757 |
$ 1,545 |
|
Capital expenditures |
(109) |
(119) |
(418) |
(474) |
|
Adjusted free cash flow (non-GAAP) |
$ 628 |
$ 621 |
$ 1,339 |
$ 1,071 |
|
Transaction cost payments associated with the Intended Business Separations |
12 |
— |
12 |
— |
|
Transaction-adjusted free cash flow (non-GAAP) |
$ 640 |
$ 621 |
$ 1,351 |
$ 1,071 |
|
|
|
|
|
|
|
Adjusted earnings (non-GAAP) 3 |
$ 494 |
$ 415 |
$ 1,236 |
$ 1,194 |
|
Adjusted free cash flow conversion (non-GAAP) |
127 % |
150 % |
108 % |
90 % |
|
Transaction-adjusted free cash flow conversion (non-GAAP) |
130 % |
150 % |
109 % |
90 % |
|
|
|
|
1. |
Adjusted Free Cash Flow and Transaction-Adjusted Free Cash Flow are calculated on a continuing operations basis for all periods presented. Refer to the definitions of Non-GAAP metrics on pages 6-7 for additional information. |
|
2. |
Refer to the Consolidated Statement of Cash Flows included in the schedules above for major GAAP cash flow categories as well as further detail relating to the changes in "Cash provided by operating activities - continuing operations" for the nine month periods noted. |
|
3. |
Refer to pages 13-14 for the Non-GAAP reconciliations of Net income from continuing operations available for DuPont common stockholders to Adjusted Earnings (Non-GAAP). |
|
Selected Financial Information and Non-GAAP Measures
|
||||
|
|
||||
|
Significant Items Impacting Results for the Three Months Ended |
||||
|
In millions, except per share amounts (Unaudited) |
Pretax 1 |
Net Income 2 |
EPS 3 |
Income Statement Classification |
|
Reported earnings (GAAP) |
$ 586 |
$ 472 |
$ 1.13 |
|
|
Less: Significant items |
|
|
|
|
|
Acquisition, integration & separation costs 4 |
(43) |
(38) |
(0.09) |
Acquisition, integration and separation costs |
|
Restructuring and asset related charges - net 5 |
(21) |
(16) |
(0.04) |
Restructuring and asset related charges - net |
|
Inventory write-offs 6 |
(2) |
(1) |
— |
Cost of sales |
|
Inventory step-up amortization 7 |
(2) |
(1) |
— |
Cost of sales |
|
Interest rate swap mark-to-market gain 8 |
191 |
147 |
0.35 |
Sundry income (expense) - net |
|
Interest rate swap amortization 9 |
(1) |
— |
— |
Interest expense |
|
Total significant items |
$ 122 |
$ 91 |
$ 0.22 |
|
|
Less: Amortization of intangibles |
(149) |
(116) |
(0.28) |
Amortization of intangibles |
|
Less: Non-op pension / OPEB benefit credits |
4 |
3 |
0.01 |
Sundry income (expense) - net |
|
Adjusted earnings (non-GAAP) |
$ 609 |
$ 494 |
$ 1.18 |
|
|
Significant Items Impacting Results for the Three Months Ended |
||||
|
In millions, except per share amounts (Unaudited) |
Pretax 1 |
Net Income 2 |
EPS 3 |
Income Statement Classification |
|
Reported earnings (GAAP) |
$ 408 |
$ 282 |
$ 0.62 |
|
|
Less: Significant items |
|
|
|
|
|
Acquisition, integration & separation costs 10 |
(9) |
(9) |
(0.02) |
Acquisition, integration and separation costs |
|
Restructuring and asset related charges - net 5 |
(8) |
(6) |
(0.01) |
Restructuring and asset related charges - net |
|
Income tax items |
— |
6 |
0.01 |
Provision for income taxes on continuing operations |
|
Total significant items |
$ (17) |
$ (9) |
$ (0.02) |
|
|
Less: Amortization of intangibles |
(155) |
(121) |
(0.27) |
Amortization of intangibles |
|
Less: Non-op pension / OPEB benefit costs |
(3) |
(2) |
(0.01) |
Sundry income (expense) - net |
|
Less: Future reimbursable indirect costs |
(2) |
(1) |
— |
Selling, general and administrative expenses |
|
Adjusted earnings (non-GAAP) |
$ 585 |
$ 415 |
$ 0.92 |
|
|
|
|
|
1. |
Income (loss) from continuing operations before income taxes. |
|
2. |
Net income (loss) from continuing operations available for DuPont common stockholders. The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. |
|
3. |
Earnings (loss) per common share from continuing operations - diluted. |
|
4. |
Acquisition, integration and separation costs related to the Intended Business Separations, and the Spectrum and Donatelle Plastics acquisitions. |
|
5. |
Includes restructuring actions and asset related charges. |
|
6. |
Reflects raw material inventory write-offs recorded in "Cost of Sales" in connection with restructuring actions related to plant line closures within the Water & Protection segment. |
|
7. |
Reflects the amortization of an inventory step-up adjustment related to the Donatelle Plastics acquisition. |
|
8. |
Includes the non-cash mark-to-market gain related to the 2022 Swaps and 2024 Swaps and net interest settlement loss related to the 2022 Swaps. |
|
9. |
Reflects the basis amortization on the 2022 Swaps. |
|
10. |
Acquisition, integration and separation costs related to the Spectrum acquisition. |
|
Selected Financial Information and Non-GAAP Measures
|
||||
|
|
||||
|
Significant Items Impacting Results for the Nine Months Ended |
||||
|
In millions, except per share amounts (Unaudited) |
Pretax 1 |
Net Income 2 |
EPS 3 |
Income Statement Classification |
|
Reported results (GAAP) |
$ 1,149 |
$ 816 |
$ 1.94 |
|
|
Less: Significant items |
|
|
|
|
|
Acquisition, integration and separation costs 4 |
(51) |
(44) |
(0.10) |
Acquisition, integration and separation costs |
|
Restructuring and asset related charges - net 5 |
(68) |
(50) |
(0.12) |
Restructuring and asset related charges - net |
|
Inventory write-offs 6 |
(26) |
(20) |
(0.05) |
Cost of sales |
|
Inventory step-up amortization 7 |
(2) |
(1) |
— |
Cost of sales |
|
Loss on debt extinguishment 8 |
(74) |
(57) |
(0.14) |
Sundry income (expense) - net |
|
Interest rate swap mark-to-market gain 9 |
152 |
118 |
0.28 |
Sundry income (expense) - net |
|
Interest rate swap amortization 10 |
(1) |
(1) |
— |
Interest expense |
|
Income tax items 11 |
8 |
(29) |
(0.07) |
Sundry income (expense) - net; Provision |
|
Total significant items |
$ (62) |
$ (84) |
$ (0.20) |
|
|
Less: Amortization of intangibles |
(449) |
(347) |
(0.83) |
Amortization of intangibles |
|
Less: Non-op pension / OPEB benefit credits |
14 |
11 |
0.03 |
Sundry income (expense) - net |
|
Adjusted earnings (non-GAAP) |
$ 1,646 |
$ 1,236 |
$ 2.94 |
|
|
Significant Items Impacting Results for the Nine Months Ended |
||||
|
In millions, except per share amounts (Unaudited) |
Pretax 1 |
Net Income 2 |
EPS 3 |
Income Statement Classification |
|
Reported results (GAAP) |
$ 1,120 |
$ 802 |
$ 1.75 |
|
|
Less: Significant items |
|
|
|
|
|
Acquisition, integration and separation costs 12 |
(15) |
(14) |
(0.03) |
Acquisition, integration and separation costs |
|
Restructuring and asset related charges - net 5 |
(39) |
(30) |
(0.06) |
Restructuring and asset related charges - net |
|
Gain on divestiture 13 |
7 |
6 |
0.01 |
Sundry income (expense) - net |
|
Income tax items |
— |
5 |
0.01 |
Provision for income taxes on continuing operations |
|
Total significant items |
$ (47) |
$ (33) |
$ (0.07) |
|
|
Less: Amortization of intangibles |
(448) |
(350) |
(0.77) |
Amortization of intangibles |
|
Less: Non-op pension / OPEB benefit costs |
(7) |
(5) |
(0.01) |
Sundry income (expense) - net |
|
Less: Future reimbursable indirect costs |
(6) |
(4) |
(0.01) |
Selling, general and administrative expenses |
|
Adjusted earnings (non-GAAP) |
$ 1,628 |
$ 1,194 |
$ 2.61 |
|
|
|
|
|
1. |
Income (loss) from continuing operations before income taxes. |
|
2. |
Net income (loss) from continuing operations available for DuPont common stockholders. The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. |
|
3. |
Earnings (loss) per common share from continuing operations - diluted. |
|
4. |
Acquisition, integration and separation costs related to the Intended Business Separations and the Spectrum and Donatelle Plastics acquisitions. |
|
5. |
Includes restructuring actions and asset related charges. |
|
6. |
Reflects net raw material inventory write-offs recorded in "Cost of Sales" in connection with restructuring actions related to plant line closures within the Water & Protection segment. |
|
7. |
Reflects the amortization of an inventory step-up adjustment related to the Donatelle Plastics acquisition. |
|
8. |
Reflects the loss on extinguishment of debt related to the partial redemption of the 2038 notes. |
|
9. |
Includes the non-cash mark-to-market gain related to the 2022 Swaps and 2024 Swaps and net interest settlement loss related to the 2022 Swaps. |
|
10. |
Reflects the basis amortization on the 2022 Swaps. |
|
11. |
Reflects the impact of an international tax audit. |
|
12. |
Acquisition, integration and separation costs related to Spectrum acquisition. |
|
13. |
Reflects post-closing adjustments related to previously divested businesses. |
View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-reports-third-quarter-2024-results-302295916.html
SOURCE DuPont
